BioIQ announces new leadership team to solve and scale COVID-19 testing. Read More

Former US Surgeon General and Ernst & Young Execs Join BioIQ for Webinar Addressing Workforce Leadership and Safety During and After the Pandemic

The July 29th webinar will help business leaders and executives to guide their organizations and provide tactical tools to operate in the new normal, return to work, and prepare for the future of work. 

ATLANTA, July 22, 2020 –  BioIQ, a healthcare engagement and clinical adherence technology platform company, announces a webinar addressing the leadership mindset and innovative ways employers can improve worker safety and wellness using industry insights and lessons learned during the current coronavirus pandemic. Former US Surgeon General Dr. Regina Benjamin will join Ernst & Young LLP (EY) Managing Director, People Advisory Services, Chuck Moritt and EY Senior Manager, Risk Transformation, Colleen Webster, along with BioIQ Co-Founder and CEO Justin Bellante for a live presentation taking place at 3p.m. Eastern on Wednesday, July 29th.

The panel of experts will discuss critical steps business leaders should take now to support employee health today and moving forward, including:

  • Leadership guidance for a pandemic
  • Tactical tools for leaders that need to be applied to employee health and safety programs
  • Tips for harnessing the new normal to drive long-term workforce success

“As employers tackle the new challenges brought on by the current pandemic, we have a unique opportunity to step up as leaders, and to leverage what we’ve learned to enact a long-lasting strategy that ensures the ongoing health and safety of US employees,” said BioIQ CEO Justin Bellante. “We are thrilled to work with the likes of Dr. Benjamin and EY to help business leaders illuminate the best path forward.”

Business leaders, media professionals, and others are invited to register for the free virtual event.

The presentation is the second installment in a three-part webinar series exploring the critical issues business leaders must consider as part of a safe return-to-work strategy. The first webinar in the series offered insight into employee COVID-19 screening and testing protocol, legal considerations for employers, and worksite safety recommendations. An on-demand replay of the webinar “Top Three Issues Addressed in Preparing/Continuing Your Return to the Workplace” is available here.

Organizations seeking assistance with COVID-19 testing and return-to-work initiatives can contact BioIQ at 888-818-1594 or visit www.bioiq.com/covid-19-solution to learn more.

About BioIQ
BioIQ is a healthcare engagement and clinical adherence technology platform company that is redefining the way payers, employers, and consumers navigate and connect with the US healthcare system. BioIQ leverages consumer analytics, real-time program intelligence, omnichannel personalized engagement strategies, and an extensive ecosystem of healthcare partners to provide a comprehensive view of individuals throughout their health journey and engage them to get testing and care that leads to healthier outcomes.

With more than a decade of healthcare industry experience and a first-of-its-kind health connectivity platform, BioIQ is uniquely positioned at the convergence of population health and the consumerization and retailization of healthcare to drive the shift to value-based care for payers and employers. Since 2005, BioIQ has launched thousands of successful health testing programs serving millions of participants. For more information, visit www.bioiq.com.

BioIQ Contact:
Judson Phillips
VP Marketing
805-504-8586 x7
jphillips@bioiq.com